Weizmann Institute of Science
Graduate-only research university in Rehovot dedicated to natural and exact sciences. Home to Nobel laureates, the RSA co-inventor, and Yeda — one of the world's most productive tech-transfer offices.
The Weizmann Institute of Science is a public research university in Rehovot, Israel, dedicated exclusively to graduate-level and postdoctoral research in the natural and exact sciences. It is consistently ranked among the top research institutions globally and has produced foundational breakthroughs in physics, chemistry, mathematics, biology, and computer science.
Founding
The institute was established in 1934 as the Daniel Sieff Research Institute by Chaim Weizmann — a chemist who later became the first President of Israel — and renamed the Weizmann Institute of Science in 1949. Unlike Israeli universities that combine undergraduate and graduate education, Weizmann admits only graduate students (M.Sc. and Ph.D.) and postdoctoral fellows, allowing it to concentrate resources entirely on research output.
Research Impact
Weizmann researchers have won Nobel Prizes, Fields Medals, and Turing Awards. The institute's contributions include foundational work in structural biology, particle physics, renewable energy, brain science, and applied mathematics. Its Department of Computer Science and Applied Mathematics produced seminal contributions to cryptography, computational complexity, and artificial intelligence. Faculty member Adi Shamir co-invented the RSA encryption algorithm — the foundation of modern internet security.
Technology Transfer
Yeda Research and Development, the Weizmann Institute's technology transfer arm, is one of the most productive academic licensing offices in the world. Yeda has generated billions of dollars in licensing revenue, with its most commercially successful spinout being the development of Copaxone (glatiramer acetate), a multiple sclerosis drug that became a multi-billion-dollar annual revenue product for Teva Pharmaceutical Industries. Weizmann spinouts operate across pharma, biotech, cleantech, and AI.
Funding Model
The Weizmann Institute is supported by a global network of "Friends of" organizations — the American Committee for the Weizmann Institute, the Canadian Institute, and equivalents in Europe, Latin America, and Asia — that collectively constitute one of the largest diaspora-funded academic endowments outside the United States. This fundraising architecture enables research independence and long-horizon science that is unusual for institutions of its size.